AOD-9604
$ 96
AOD9604 is a modified analog of the hGH Fragment 176–191 peptide, containing a stabilized disulfide bridge, and is therefore a derivative of human growth hormone (hGH). It was originally developed and studied for its potential lipolytic properties, specifically its ability to influence fat metabolism.
In preclinical and research settings, AOD9604 has been investigated for its role in stimulating lipolysis (the breakdown of stored fat) while inhibiting lipogenesis (the formation of new fat). Beyond metabolic research, studies have also explored its potential relevance in areas such as cardiovascular health, osteoarthritis, cartilage repair, and metabolic syndrome.
Due to these characteristics, AOD9604 continues to attract interest within the scientific community as a compound of interest for metabolic and regenerative research applications. All materials are intended strictly for laboratory research purposes only.
Description
AOD9604 is a synthetic peptide derived from human growth hormone (hGH) Fragment 176–191, a region of the HGH molecule associated with lipid metabolism. This modified analogue contains a stabilizing disulfide bridge, allowing researchers to study its biological activity while maintaining structural similarity to the original growth hormone fragment.
Originally investigated for its potential role in fat metabolism research, AOD9604 has demonstrated activity related to **lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) in preclinical studies. Unlike full-length growth hormone, research suggests that AOD9604 may exhibit minimal interaction with IGF-1 and insulin pathways, making it a compound of interest in metabolic and obesity-related research models.
Beyond metabolic studies, AOD9604 has also been explored in experimental research involving cartilage physiology, joint function, and metabolic health, though these mechanisms continue to be investigated.
—
Molecular Information
Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Disulfide Bridge: Cys7–Cys15
Molecular Formula: C78H123N23O23S2
Molecular Weight: 1815.12 g/mol
CAS Number: 386264-39-7
—
Research Use Only
All products supplied by Longevra Peptide Research are intended strictly for laboratory research and in-vitro studies. These compounds are not intended for human or veterinary use, are not approved by the FDA as medicines, and must be handled only by qualified research professionals in controlled laboratory environments.
Reviews
There are no reviews yet.